Cargando…
Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19
Introduction. Determining the profile of COVID-19 patients with low pulsed hemoglobin saturation in oxygen (SpO(2)) could help clinicians identify those with a poor prognosis. Aim. To identify and to compare the clinical, biological and radiological data of Algerian patients hospitalized for COVID-1...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tunisian Society of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796682/ https://www.ncbi.nlm.nih.gov/pubmed/35261005 |
_version_ | 1784641380231938048 |
---|---|
author | Ketfi, Abdelbassat Touahri, Rama Chabati, Omar Chemali, Samia Mahjoub, Mohamed Gharnaout, Merzak Djenouhat, Kamel Selatni, Fayçal Ben Saad, Helmi |
author_facet | Ketfi, Abdelbassat Touahri, Rama Chabati, Omar Chemali, Samia Mahjoub, Mohamed Gharnaout, Merzak Djenouhat, Kamel Selatni, Fayçal Ben Saad, Helmi |
author_sort | Ketfi, Abdelbassat |
collection | PubMed |
description | Introduction. Determining the profile of COVID-19 patients with low pulsed hemoglobin saturation in oxygen (SpO(2)) could help clinicians identify those with a poor prognosis. Aim. To identify and to compare the clinical, biological and radiological data of Algerian patients hospitalized for COVID-19 and divided according to the SpO(2) measured at admission, at rest, and in ambient air. Methods. A prospective study was carried out on Algerian patients hospitalized for COVID-19 during the period from March 9 to April 30, 2020. The general characteristics of the patients and the clinical, biological and radiological data were determined. Results. 86 patients were included in the study [G(1): SpO(2 )>95% (n=51) and G(2): SpO(2) ≤95% (n=35)]. Compared to G(1), G(2) was older (48±14 vs. 61±12 years, p=0.0001), included more patients aged ≥ 50 years (37.2 vs. 80.0%, p=0.0001), having an arterial-hypertension (21.6 vs. 45.7%, p=0.0180), a cancer (0.0 vs. 14.3%, p=0.0054), an anemia (25.6 vs. 56.3%, p=0.0069), a leukocytosis (4.7 vs. 21.9%, p=0.0236), a biological inflammatory syndrome (82.5 vs. 100%, p=0.0142), a hyper-uremia (7.0 vs. 37.5%, p=0.0185), a hyper-creatininaemia (4.7 vs. 18.8%, p=0.0356), a tissue damage (41.0 vs. 66.7%, p=0.0341), a diffuse ground-glass opacity (52.0 vs. 71.4%, p=0.0397), band condensations (30.0 vs. 54.3%, p=0.0244), a severe extension (2.0 vs. 25.7%, p=0.0008), and included fewer patients who complained from diarrhea (49.0 vs. 22.9%, p=0.0145), having a nodular ground-glass (66.0 vs. 40.0%, p=0.0177) and a slight extension (78.0 vs. 40.0%, p=0.0004). Conclusion. Criteria associated with low SpO(2) in hospitalized COVID-19 patients were advanced age, a history of arterial-hypertension and cancer, high frequencies of certain biological abnormalities or radiological signs. The diarrhea symptom, the radiological appearance of nodular ground glass, and a slight extension of the radiological lesions appear as protective elements. |
format | Online Article Text |
id | pubmed-8796682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Tunisian Society of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-87966822022-01-31 Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19 Ketfi, Abdelbassat Touahri, Rama Chabati, Omar Chemali, Samia Mahjoub, Mohamed Gharnaout, Merzak Djenouhat, Kamel Selatni, Fayçal Ben Saad, Helmi Tunis Med Article Introduction. Determining the profile of COVID-19 patients with low pulsed hemoglobin saturation in oxygen (SpO(2)) could help clinicians identify those with a poor prognosis. Aim. To identify and to compare the clinical, biological and radiological data of Algerian patients hospitalized for COVID-19 and divided according to the SpO(2) measured at admission, at rest, and in ambient air. Methods. A prospective study was carried out on Algerian patients hospitalized for COVID-19 during the period from March 9 to April 30, 2020. The general characteristics of the patients and the clinical, biological and radiological data were determined. Results. 86 patients were included in the study [G(1): SpO(2 )>95% (n=51) and G(2): SpO(2) ≤95% (n=35)]. Compared to G(1), G(2) was older (48±14 vs. 61±12 years, p=0.0001), included more patients aged ≥ 50 years (37.2 vs. 80.0%, p=0.0001), having an arterial-hypertension (21.6 vs. 45.7%, p=0.0180), a cancer (0.0 vs. 14.3%, p=0.0054), an anemia (25.6 vs. 56.3%, p=0.0069), a leukocytosis (4.7 vs. 21.9%, p=0.0236), a biological inflammatory syndrome (82.5 vs. 100%, p=0.0142), a hyper-uremia (7.0 vs. 37.5%, p=0.0185), a hyper-creatininaemia (4.7 vs. 18.8%, p=0.0356), a tissue damage (41.0 vs. 66.7%, p=0.0341), a diffuse ground-glass opacity (52.0 vs. 71.4%, p=0.0397), band condensations (30.0 vs. 54.3%, p=0.0244), a severe extension (2.0 vs. 25.7%, p=0.0008), and included fewer patients who complained from diarrhea (49.0 vs. 22.9%, p=0.0145), having a nodular ground-glass (66.0 vs. 40.0%, p=0.0177) and a slight extension (78.0 vs. 40.0%, p=0.0004). Conclusion. Criteria associated with low SpO(2) in hospitalized COVID-19 patients were advanced age, a history of arterial-hypertension and cancer, high frequencies of certain biological abnormalities or radiological signs. The diarrhea symptom, the radiological appearance of nodular ground glass, and a slight extension of the radiological lesions appear as protective elements. Tunisian Society of Medical Sciences 2021-07 2021-07-01 /pmc/articles/PMC8796682/ /pubmed/35261005 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Article Ketfi, Abdelbassat Touahri, Rama Chabati, Omar Chemali, Samia Mahjoub, Mohamed Gharnaout, Merzak Djenouhat, Kamel Selatni, Fayçal Ben Saad, Helmi Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19 |
title | Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19 |
title_full | Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19 |
title_fullStr | Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19 |
title_full_unstemmed | Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19 |
title_short | Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19 |
title_sort | facteurs de sévérité chez les patients algériens hospitalisés pour covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796682/ https://www.ncbi.nlm.nih.gov/pubmed/35261005 |
work_keys_str_mv | AT ketfiabdelbassat facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 AT touahrirama facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 AT chabatiomar facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 AT chemalisamia facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 AT mahjoubmohamed facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 AT gharnaoutmerzak facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 AT djenouhatkamel facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 AT selatnifaycal facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 AT bensaadhelmi facteursdeseveritechezlespatientsalgerienshospitalisespourcovid19 |